0001062993-19-001099 Sample Contracts

SECOND AMENDMENT TO SECOND AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT

Development and License Agreement • February 28th, 2019 • Biospecifics Technologies Corp • Pharmaceutical preparations • New York

• Contract Type
  Development and License Agreement
• Filed
  February 28th, 2019
• Company
  Biospecifics Technologies Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This SECOND AMENDMENT TO SECOND AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT dated February 26, 2019, with an effective date as of January 1, 2019 (the “Second Amendment Effective Date”), is by and between BioSpecifics Technologies Corp., a Delaware corporation (“BTC”), and Endo Global Ventures, a Bermuda unlimited liability company (“Endo”). BTC and Endo shall sometimes be referred to herein collectively as “Parties.”